Pfizer announces $750M investment to expand SW Michigan facility

Article Summary

Pfizer announced on Monday it is investing $750 million to expand its Southwest Michigan pharmaceutical facility.

 

The company says the Modular Aseptic Processing (MAP) Phase 2 expansion will create 300 jobs. Officials say the facility near Kalamazoo, where Pfizer first mass produced its COVID-19 vaccine, will advance its sterile manufacturing technology. It will also utilize new mRNA technology and ultra-low temperature shortage.

 

“Since 2017, Pfizer has invested $5 billion to support the ongoing growth of our manufacturing leadership in the U.S.” Albert Bourla, Chairman and CEO of Pfizer, said in a statement. “This expansion is part of our blueprint to grow our U.S. manufacturing base, create more manufacturing jobs, and help ensure patients everywhere can get the medicines they need.”

 

The expansion will add to the $465 million investment of the company’s sterile injectable production facilities. Additionally, Pfizer announced a $120 million investment to expand production of the COVID-19 oral treatment, Paxlovid.

 

Gov. Gretchen Whitmer, who joined Pfizer officials on Monday, said the company “is making another bold bet on Michigan’s manufacturing strengths and hardworking people.”

 

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com. 

 

(Source: CBS DETROIT, 5th Dec 2022) 

Comments

Leave A Comment

Leave a Reply

Your email address will not be published.

bag